"We now expect revenues to be between $11.95 billion and $12.05 billion... Reported EPS to be in a range of $9.97 to $10.17 and adjusted EPS in a range of $11.05 to $11.25." (Executive VP & CFO Samad) ...

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests Quest Diagnostics (NYSE:DGX) reported double-digit revenue ...

Quest Diagnostics Incorporated DGX stock surged Thursday after the diagnostic testing company reported second-quarter results ...

Finding a vacuum cleaner that can tackle dust, dirt and pet hair while suiting your home and budget isn’t always easy. To ...

The lab firm said it now expects full-year net revenue in the range of $11.95 billion to $12.05 billion, up from its previous guidance of $11.78 billion to $11.90 billion.

Second quarter revenues of $3.04 billion, up 10.2% from 2025, with 10.0% organic revenue growth Second quarter reported diluted earnings per share ("EPS") of $2.84 ...

The England and Wales Cricket Board (ECB) has unveiled a packed home schedule for 2027, headlined by the men's five-Test ...

Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped ​the company beat second-quarter estimates.

Quest Diagnostics raised its full-year outlook after profit and sales rose in the second quarter. The diagnostic testing company on Thursday posted a profit of $320 million, or $2.84 a share, in the ...

Quest Diagnostics crushed Q2 earnings with a 10.5% EPS beat fueled by a 13.1% surge in testing volume, lifting the company's full-year guidance on broad momentum in Alzheimer's blood tests and ...

England will begin their quest to regain the men's Ashes from Australia at Trent Bridge on 18 June next year, with the ...

Quest Diagnostics, the world’s leading provider of diagnostic information services, said demand for COVID-19 tests “continues ...